文献速递慢性肾脏病水电解质与酸碱

蛋白尿与FGF-23活性及血磷交互作用对CKD进展的影响:KNOW-CKD队列研究

The effect of interactions between proteinuria, activity of fibroblast growth factor 23 and serum phosphate on renal progression in patients with chronic kidney disease: a result from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease study.
PubMed 文献 · Nephrol Dial Transplant · 2020-01-01

该研究基于韩国CKD前瞻性队列1909例患者,发现24小时尿蛋白与磷排泄分数/FGF-23比值(FEP/FGF-23)呈负相关,蛋白尿更多者血磷更高、FGF-23更高而FEP/FGF-23更低;低FEP/FGF-23是CKD进展的独立危险因素,且尿蛋白与FEP/FGF-23及血磷对CKD进展存在显著交互作用。

要点

  • 蛋白尿程度越高,FGF-23生物学活性越低(FEP/FGF-23比值越低)。
  • 低FEP/FGF-23比值是蛋白尿性CKD患者肾脏进展的独立危险因素。
  • 尿蛋白与FGF-23活性及血磷对CKD进展存在显著交互作用。

核心结论

  • 蛋白尿与FGF-23生物学活性降低及血磷升高相关。
  • FGF-23活性降低是蛋白尿性CKD患者肾脏进展的独立危险因素。
  • 尿蛋白与FEP/FGF-23比值及血磷对CKD进展存在显著交互作用。

研究设计与样本

  • 韩国KNOW-CKD前瞻性队列研究,纳入1909例CKD患者。
  • 以磷排泄分数与FGF-23比值(FEP/FGF-23)评估FGF-23生物学活性。
  • 主要结局为CKD进展:eGFR下降≥50%、血肌酐翻倍或开始透析。

主要发现

  • 24小时尿蛋白与FEP/FGF-23比值呈负相关(γ -0.07;P = 0.005)。
  • 匹配血磷相关变量后,蛋白尿更多者血磷更高(P < 0.001)、FGF-23更高(P = 0.012)、FEP/FGF-23更低(P = 0.007)。
  • 匹配队列中低FEP/FGF-23是CKD进展独立危险因素(每1 log增加HR 0.87;95%CI 0.79-0.95;P = 0.002)。
  • 24小时尿蛋白与FEP/FGF-23比值对CKD进展存在显著交互作用(P = 0.039)。
  • 24小时尿蛋白与血磷对CKD进展存在显著交互作用(P < 0.001)。

临床怎么用

  • 对蛋白尿性CKD患者可关注FGF-23生物学活性(FEP/FGF-23比值)以辅助评估肾脏进展风险。
  • 蛋白尿管理可能有助于改善FGF-23活性及血磷控制,但需进一步干预研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent experimental study reported that proteinuria increases serum phosphate by decreasing biologic activity of fibroblast growth factor 23 (FGF-23). We examined this relationship in a large chronic kidney disease (CKD) cohort and evaluated the combined effect of proteinuria, FGF-23 activity and serum phosphate on CKD progression. METHODS: The activity of FGF-23, measured by the fractional excretion of phosphate (FEP)/FGF-23 ratio, was compared according to the degree of proteinuria in 1909 patients with CKD. Primary outcome was CKD progression defined as ≥50% decline of estimated glomerular filtration rate, doubling of serum creatinine and start of dialysis. RESULTS: There was a negative relationship between 24-h urine protein (24-h UP) and FEP/FGF-23 ratio (γ -0.07; P = 0.005). In addition, after matching variables associated with serum phosphate, patients with more proteinuria had higher serum phosphate (P < 0.001) and FGF-23 (P = 0.012), and lower FEP/FGF-23 ratio (P = 0.007) compared with those with less proteinuria. In the matched cohort, low FEP/FGF-23 ratio was an independent risk factor for CKD progression (hazard ratio 0.87 per 1 log increase; 95% confidence interval 0.79-0.95; P = 0.002), and there was significant interaction between 24-h UP and FEP/FGF-23 ratio (P = 0.039). Furthermore, 24-h UP and serum phosphate also had a significant interaction on CKD progression (P < 0.001). CONCLUSIONS: Proteinuria is associated with decreased biologic activity of FGF-23 and increased serum phosphate. Furthermore, diminished activity of FGF23 is an independent risk factor for renal progression in proteinuric CKD patients.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Kim H, Park J, Nam KH, et al. The effect of interactions between proteinuria, activity of fibroblast growth factor 23 and serum phosphate on renal progression in patients with chronic kidney disease: a result from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease study. Nephrol Dial Transplant. 2020. PMID: 30615179. doi:10.1093/ndt/gfy403

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。